Skip to content
GERICLINICS

GeriQBank · Paper IV · Q1

Investigation and Management of Diabetic Ketoacidosis

High YieldAsked ×220-mark essay
Chapter
Endocrine, Metabolic, Renal & Genitourinary Systems
Years asked
Not recorded in the source
Frequency
Set 2× in Paper IV (2009–2025)

As set in the university papers — 2 wordings

  • Discuss the causes of coma in elderly people. (Asked together with: how will you investigate and manage diabetic ketoacidosis?)

    Paper IV · Neurology · asked ×1 · 20-mark essay · see in paper list

  • How will you investigate and manage diabetic ketoacidosis? (Asked paired with: causes of coma in elderly people.)

    Paper IV · Endocrine & Metabolic · asked ×1 · 20-mark essay · see in paper list

Answer framework

  1. Definition and concept — the triad; DKA versus HHS and mixed states in older people; worse outcomes in old age
  2. Precipitating factors — infection, MI, stroke, insulin omission, drugs; care-home and dementia risks
  3. Clinical features — blunted classical symptoms; signs to look for
  4. Investigations — glucose, venous gas, β-OHB, electrolytes and osmolality, the search for a precipitant; diagnostic criteria; euglycaemic DKA
  5. Management — fluids; fixed-rate insulin; potassium; dextrose, bicarbonate, phosphate; resolution and switching to subcutaneous insulin; complications; prevention
  6. Recent updates — 2024 consensus changes, subcutaneous insulin protocols, HHS criteria, SGLT2 inhibitors, ADA advice for older adults, the 0.45% saline debate

An exam answer plan drawn from the detailed answer below. Use it to attempt the question first.

Detailed answer

Pro · free in beta
Attempt it firstOutline your answer as a 20-mark essay before revealing it — definition, causes, evaluation, management and the geriatric angle.Reveal answer

Short revision answer

  • DKA is hyperglycaemia, ketosis and acidosis from insulin deficiency with excess counter-regulatory hormones. Older people get HHS more often, and many have a mixed picture (glucose 270–450 mg/dL, pH 7.2–7.3). They have higher mortality, longer stays, more newly diagnosed diabetes and more renal impairment.
  • Precipitants: infection (chest, urine, foot), MI, stroke, omitted insulin, and drugs (thiazides and steroids; thiazides and furosemide especially for HHS). Care-home living, dementia, impaired thirst and dependence on carers add risk.
  • Classical symptoms may be absent: older patients present with confusion, falls, drowsiness, incontinence or poor intake. Look for Kussmaul breathing, ketotic breath, dehydration, hypotension and abdominal pain; hypothermia may mask sepsis.
  • Investigate: glucose; a venous gas; bedside β-OHB (preferred over urine ketones); corrected sodium, potassium, bicarbonate, urea and creatinine; effective osmolality (2 × Na + glucose/18) for HHS overlap; FBC, CRP, cultures, chest X-ray, ECG and troponin, and the feet.
  • Diagnosis (2024 consensus): glucose ≥200 mg/dL or known diabetes; β-OHB ≥3.0 mmol/L (or urine ketones ≥2+); pH <7.3 and/or bicarbonate <18 mEq/L. Exclude euglycaemic DKA with SGLT2 inhibitors, starvation or liver disease.
  • Fluids first: 0.9% saline or a balanced crystalloid, about 1 litre in the first hour, given more slowly with heart failure or CKD. Fixed-rate insulin at 0.1 units/kg/hour without a bolus, aiming for β-OHB to fall by 0.5 mmol/L/hour and glucose by 50–75 mg/dL/hour.
  • Potassium: withhold insulin if K <3.3 mEq/L; add 20–40 mEq/L to fluids when K is 3.3–5.2; give none if K >5.2. Add 5–10% dextrose when glucose reaches about 250 mg/dL and keep insulin running until ketosis clears. Bicarbonate only if pH <7.0.
  • Resolution: β-OHB <0.6 mmol/L with pH >7.3 or bicarbonate ≥18. Start subcutaneous basal insulin 1–2 hours before stopping the infusion. Prevent hypoglycaemia, hypokalaemia, fluid overload, aspiration and VTE; prevent recurrence with sick-day rules, home ketone meters and education for carers.
  • Updates: the 2024 consensus dropped the anion gap and arterial gases, built β-OHB into diagnosis and resolution, allowed subcutaneous rapid-acting insulin on the ward for mild DKA, and defined HHS resolution. Withhold SGLT2 inhibitors during acute illness, fasting and surgery. The ADA advises de-intensifying treatment in frail older adults.

Condensed by GeriClinics from the detailed answer below, with no new facts added.

A. Definition and Basic Concept

1.

DKA is an acute metabolic emergency defined by the triad of hyperglycaemia, ketosis and metabolic acidosis, caused by absolute or relative insulin deficiency with excess counter-regulatory hormones.

2.

In older people DKA is less common than HHS (hyperosmolar hyperglycaemic state), but many elderly patients present with a “mixed” picture — glucose 270–450 mg/dL, pH 7.2–7.3, without marked dehydration or coma.

3.

Older subjects with hyperglycaemic comas have higher mortality, longer hospital stay, more previously undiagnosed diabetes, more renal impairment, and need larger insulin doses than the young.

B. Precipitating Factors in the Elderly

4.

Commonest precipitants are infection (chest, urine, foot), myocardial infarction, stroke, inadequate or omitted insulin, and inappropriate drug treatment.

5.

Thiazide diuretics and corticosteroids raise blood glucose and can precipitate DKA; thiazides and furosemide particularly precipitate HHS.

6.

Care-home residence, dementia, thirst impairment and dependence on carers are important risk factors; COVID-19 and other acute illness can cause rapid decompensation.

C. Clinical Features

7.

Classical polyuria, polydipsia and weight loss may be absent or blunted; presentation is often non-specific — confusion, falls, drowsiness, incontinence, poor oral intake.

8.

Look for Kussmaul breathing, ketotic breath, dehydration, hypotension, tachycardia and abdominal pain; hypothermia and absent fever may mask underlying sepsis.

D. Investigations

9.

Capillary and venous blood glucose; venous (not arterial) blood gas for pH and bicarbonate.

10.

Bedside quantitative beta-hydroxybutyrate (β-OHB) is the preferred ketone test; urine ketones (nitroprusside) detect only acetoacetate and are less reliable.

11.

Serum electrolytes — sodium (corrected for glucose), potassium, chloride, bicarbonate; anion gap; blood urea and creatinine.

12.

Effective serum osmolality = 2 × Na (mEq/L) + glucose (mg/dL)/18 — to identify overlap with HHS.

13.

Search for precipitant: full blood count, CRP, blood and urine cultures, chest X-ray, ECG and troponin (silent infarction is common), foot examination.

14.

Diagnostic criteria (current international consensus): glucose ≥200 mg/dL or known diabetes; β-OHB ≥3.0 mmol/L or urine ketones ≥2+; pH <7.3 and/or bicarbonate <18 mEq/L. Severity is graded by pH, bicarbonate and mental state.

15.

Euglycaemic DKA (glucose <200 mg/dL) must be actively excluded in patients on SGLT2 inhibitors, in starvation, and in chronic liver disease.

E. Management

16.

Fluids first — 0.9% saline or balanced crystalloid, typically 1 litre over the first hour, then titrated. In the elderly with heart failure or CKD, give slower and monitor closely for pulmonary oedema.

17.

Fixed-rate intravenous insulin infusion 0.1 units/kg/hour, without a bolus in most patients; aim to fall β-OHB by 0.5 mmol/L/hour and glucose by 50–75 mg/dL/hour.

18.

Potassium: withhold insulin if K <3.3 mEq/L until replaced; add 20–40 mEq/L to fluids when K is 3.3–5.2 mEq/L; withhold if K >5.2 mEq/L.

19.

Add 5–10% dextrose when glucose falls to about 250 mg/dL, continuing insulin until ketosis clears. Bicarbonate only if pH <7.0; phosphate only if <1.0 mg/dL with cardiac or respiratory weakness.

20.

Resolution: β-OHB <0.6 mmol/L with pH >7.3 or bicarbonate ≥18 mEq/L; then overlap intravenous insulin with subcutaneous basal insulin by 1–2 hours before stopping the infusion.

21.

Complications to prevent: hypoglycaemia, hypokalaemia, fluid overload, aspiration, venous thromboembolism, and (rarely in old age) cerebral oedema.

22.

Prevention: sick-day rules, ketone meters at home, structured education of patients and care-home staff, avoidance of insulin omission, and review of diabetogenic drugs.

Latest Updates (2023–Present)

ADA/EASD/AACE/JBDS/DTS Consensus Report on Hyperglycaemic Crises in Adults (Diabetes Care, 2024) — the first major revision in 15 years. Key changes: glucose threshold lowered to ≥200 mg/dL or a known history of diabetes (to capture euglycaemic DKA); quantitative β-OHB incorporated into diagnosis, severity grading and resolution; the anion gap criterion removed; arterial sampling abandoned in favour of venous gases. The same consensus simplified treatment to three pillars — fluids, insulin and potassium, and for the first time endorsed subcutaneous rapid-acting insulin protocols in a non-critical-care ward for mild and uncomplicated moderate DKA.

The 2024 consensus provides the first formal HHS resolution criteria (normalisation of effective osmolality and recovery of mental status) and redefines HHS hyperosmolarity as effective osmolality >300 mOsm/kg or calculated total osmolality >320 mOsm/kg.

SGLT2 inhibitor–associated euglycaemic DKA is now a recognised inpatient hazard; current guidance is to withhold SGLT2 inhibitors during acute illness, fasting and around surgery, which is directly relevant to older multimorbid patients.

ADA Standards of Care (2025 and 2026), Older Adults section — reiterates that in frail and care-dependent older adults, treatment should be simplified and de-intensified, with the primary aim of avoiding both hypoglycaemia and hyperglycaemic crisis rather than achieving a tight HbA1c.

Published commentary on the 2024 consensus has questioned the omission of 0.45% saline, since many patients have true free-water deficits once sodium is corrected for hyperglycaemia — a practical caution in the dehydrated older patient.

Current Practice Update

Aspect Textbook Position Current Evidence / Guideline Ketone assessment Urine ketones / clinical acidosis Quantitative bedside β-OHB for diagnosis, severity and resolution Glucose criterion Marked hyperglycaemia expected ≥200 mg/dL or known diabetes; euglycaemic DKA formally recognised Acid–base testing Arterial blood gas, anion gap used Venous gas; anion gap dropped from criteria Insulin route Intravenous infusion for all Subcutaneous rapid-acting insulin acceptable in mild/uncomplicated moderate DKA on the ward HHS resolution Not formally defined Defined criteria — normal effective osmolality plus recovered mental status Drug precipitants Thiazides, steroids emphasised SGLT2 inhibitors added as an important modern precipitant Exam One-Liners DKA in old age is often a “mixed” DKA–HHS picture with modest acidosis.

β-OHB ≥3.0 mmol/L is the modern ketosis criterion; anion gap is no longer required. Insulin is withheld until K >3.3 mEq/L.

Add dextrose at glucose ~250 mg/dL; treat the ketosis, not the glucose.

Overlap IV and subcutaneous insulin by 1–2 hours to avoid rebound.

Suspect euglycaemic DKA in any unwell patient on an SGLT2 inhibitor.

How was your recall?

Rating marks the question complete. “Need another pass” also adds it to your bookmarks.

References

Spotted an error or something out of date?Report a problem with this page